FDA Submits Information Collection for Review by Office of Management and Budget

Summary

The Food and Drug Administration (FDA) has submitted a proposal to collect information regarding the safety of new antimicrobial animal drugs, with the aim of evaluating their potential impact on human health bacteria, for review and clearance by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995.